D.2.d J-and-A-Other-Than-Full-and-Open_Redacted.pdf

This document provides a justification and approval for a modification to a sole source contract awarded by the Centers for Disease Control and Prevention. The contract was awarded to Rush University Medical Center on March 22, 2022, in the amount of $5,874,125.14, to expand an ongoing study determining outcomes of SARS COV-2 infections by age, sex, race, and underlying conditions. The modification increases the study population to approximately 3,000 cases and 3,000 controls, extends follow-up to 27 months, and runs the period of performance through August 31, 2023. Rush University Medical Center is identified as the only contractor able to complete the required study refinements due to its work to date aligning the data management platform across eight study sites and ongoing study activities with current enrollment.